aptiganel has been researched along with triphenyltetrazolium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aronowski, J; Grotta, JC; Ostrow, P; Samways, E; Strong, R; Zivin, JA | 1 |
| Cotter, RE; Davis, MA; Fisher, M; Knapp, AG; Li, L; McBurney, RN; Minematsu, K; Sotak, CH | 1 |
2 other study(ies) available for aptiganel and triphenyltetrazolium
| Article | Year |
|---|---|
Graded bioassay for demonstration of brain rescue from experimental acute ischemia in rats.
Topics: Acute Disease; Animals; Biological Assay; Brain; Brain Ischemia; Guanidines; Hypothermia, Induced; Male; Neuroprotective Agents; Rats; Rats, Inbred SHR; Receptors, N-Methyl-D-Aspartate; Staining and Labeling; Tetrazolium Salts; Time Factors | 1994 |
Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI.
Topics: Animals; Cerebral Infarction; Cerebrovascular Disorders; Disease Models, Animal; Guanidines; Ischemic Attack, Transient; Kinetics; Magnetic Resonance Imaging; Male; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Staining and Labeling; Tetrazolium Salts; Time Factors | 1993 |